Nitric Oxide Control of MYCN Expression and Multi Drug Resistance Genes in Tumours of Neural Origin

E-ISSN： 1873-4286|16|4|431-439

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.4, 2010-02, pp. : 431-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitric Oxide Control of Proliferation in Nerve Cells and in Tumor Cells of Nervous Origin

Current Pharmaceutical Design, Vol. 16, Iss. 4, 2010-02 ,pp. : 440-450

Bentham Science Publishers

Access to resources Recommend Favorite

Transfer and expression of recombinant nitric oxide synthase genes in the cardiovascular system

By Chen A.F.Y. O'Brien T. Katusic Z.S.

Trends in Pharmacological Sciences, Vol. 19, Iss. 7, 1998-07 ,pp. : 276-286

Elsevier

Access to resources Recommend Favorite

Multi-drug resistance and cancer

By Atalay Can

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite

The Physiology of Nitric Oxide: Control and Consequences

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 3, Iss. 3, 2004-09 ,pp. : 189-205

Bentham Science Publishers

Access to resources Recommend Favorite

Application of nitric oxide in drug discovery and development

By Bryan Nathan S

Expert Opinion on Drug Discovery, Vol. 6, Iss. 11, 2011-11 ,pp. : 1139-1154

Informa Healthcare

Access to resources Recommend Favorite